Cargando…

Human Papillomavirus Prevalence and Vaccination Rates Among Users of Pre-Exposure Prophylaxis for Human Immunodeficiency Virus Prevention

INTRODUCTION: Our study provides data on the prevalence of human papillomavirus (HPV) related disease and vaccination rates among users of pre-exposure prophylaxis (PrEP) in a primary care clinic. Results highlight an opportunity to partner HIV and HPV prevention efforts. METHODS: This is a retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rotert, Paul, Wheldon, Christopher, Kownack, Jenn, Sullivan-Blum, Zoe, Cokingtin, Brendan, Khetani, Karishma, Ndeti, Kavindu, Skyes, Kevin, Ramaswamy, Megha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386814/ https://www.ncbi.nlm.nih.gov/pubmed/35972200 http://dx.doi.org/10.1177/21501319221110411

Ejemplares similares

PrEP patient attitudes, beliefs and perceived barriers surrounding HPV vaccination: a qualitative study of semistructured interviews with PrEP patients in primary care clinics in Kansas and Missouri
por: Sullivan-Blum, Zoe C, et al.
Publicado: (2022)

Incarcerated Adolescents’ Attitudes Toward Human Papillomavirus Vaccine: Report From a Juvenile Facility in Kansas
por: Allison, Molly, et al.
Publicado: (2019)

The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa
por: Williamson, Anna-Lise
Publicado: (2015)

Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia
por: Camargo, Milena, et al.
Publicado: (2014)

Qualitative investigation of factors impacting pre‐exposure prophylaxis initiation and adherence in sexual minority men
por: Alt, Marcus, et al.
Publicado: (2021)

High Prevalence of Anal and Oral High-Risk Human Papillomavirus in Human Immunodeficiency Virus–Uninfected French Men Who Have Sex With Men and Use Preexposure Prophylaxis
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2019)

Update on human papillomavirus – Part II: complementary diagnosis, treatment and prophylaxis()()
por: Araújo, Marcelo Grossi, et al.
Publicado: (2021)

The prevalence of cervical cytology abnormalities and human papillomavirus in women infected with the human immunodeficiency virus
por: Dames, Dionne N, et al.
Publicado: (2009)

Metagenomic Discovery of 83 New Human Papillomavirus Types in Patients with Immunodeficiency
por: Pastrana, Diana V., et al.
Publicado: (2018)

High Prevalence of Genital Human Papillomavirus Infection in Patients With Primary Immunodeficiencies
por: Gernert, Michael, et al.
Publicado: (2021)

Sexual Assault: A Report on Human Immunodeficiency Virus Postexposure Prophylaxis
por: Griffith, William F., et al.
Publicado: (2010)

Consensus statement on human immunodeficiency virus pre-exposure prophylaxis in China
por: Xu, Jun-Jie, et al.
Publicado: (2020)

US Black cisgender women and pre-exposure prophylaxis for human immunodeficiency virus prevention: A scoping review
por: Conley, Cherie, et al.
Publicado: (2022)

Human papillomavirus genotypes in human immunodeficiency virus-positive patients with anal pathology in Madrid, Spain
por: García-Espinosa, Benjamín, et al.
Publicado: (2013)

The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China
por: Zhang, Hong-Yun, et al.
Publicado: (2014)

High-Risk Cervical Human Papillomavirus Infections among Human Immunodeficiency Virus-Positive Women in the Bahamas
por: Dames, Dionne N., et al.
Publicado: (2014)

Increased alpha-9 human papillomavirus species viral load in human immunodeficiency virus positive women
por: Mbulawa, Zizipho ZA, et al.
Publicado: (2014)

Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence
por: Li, Xiao, et al.
Publicado: (2015)

Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status
por: Mbulawa, Zizipho Z A, et al.
Publicado: (2015)

Persistence of oncogenic and non-oncogenic human papillomavirus is associated with human immunodeficiency virus infection in Kenyan women
por: Tong, Yan, et al.
Publicado: (2020)

State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshop
por: Schuind, Anne E., et al.
Publicado: (2023)

Psychosocial correlates of human immunodeficiency virus infected patients
por: Agrawal, Megha, et al.
Publicado: (2012)

Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention
por: Glaubius, Robert L., et al.
Publicado: (2016)

Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis
por: Fulcher, Jennifer A, et al.
Publicado: (2019)

Public health significance of human immunodeficiency virus pre-exposure and post-exposure prophylaxis
por: Xu, Jun-Jie, et al.
Publicado: (2020)

Predisposing, Enabling, and Need-Related Factors Associated with Human Papillomavirus Vaccination Intentions and Uptake Among Black and Hispanic Sexual and Gender Diverse Adults in the USA
por: Wheldon, Christopher W., et al.
Publicado: (2022)

Human Papillomavirus Detection from Human Immunodeficiency Virus-Infected Colombian Women's Paired Urine and Cervical Samples
por: Munoz, Marina, et al.
Publicado: (2013)

Update on the Epidemiological Features and Clinical Implications of Human Papillomavirus Infection (HPV) and Human Immunodeficiency Virus (HIV) Coinfection
por: Pérez-González, Alexandre, et al.
Publicado: (2022)

High-risk human papillomavirus-associated vulvar neoplasia among women living with human immunodeficiency virus in Zambia
por: Maate, Fred, et al.
Publicado: (2022)

Minimum dataset for monitoring national human immunodeficiency virus pre-exposure prophylaxis (HIV PrEP) programmes: a five-nation consensus, 2019
por: Saunders, John, et al.
Publicado: (2021)

Target users’ acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)
por: MacDonald, Calum B., et al.
Publicado: (2023)

Awareness and knowledge of human immunodeficiency virus post exposure prophylaxis among Nigerian Family Physicians
por: Agaba, Patricia A., et al.
Publicado: (2012)

Administering human immunodeficiency virus post-exposure prophylaxis: challenges experienced by mothers in Lusaka, Zambia
por: Lusaka, Mildred, et al.
Publicado: (2021)

Worsening Disparities in State-Level Uptake of Human Immunodeficiency Virus Preexposure Prophylaxis, 2014–2018
por: Powers, Samuel D, et al.
Publicado: (2021)

1535. Persistence With Human Immunodeficiency Virus Pre-exposure Prophylaxis in an Active-Duty Military Population
por: Colver, Jacob T, et al.
Publicado: (2023)

High Prevalence of Human Papillomavirus Infection among Brazilian Pregnant Women with and without Human Immunodeficiency Virus Type 1
por: Jalil, Emilia Moreira, et al.
Publicado: (2009)

The Role of Human Papillomavirus in Human Immunodeficiency Virus Acquisition in Men who have Sex with Men: A Review of the Literature
por: Brown, Brandon, et al.
Publicado: (2012)

Identification of the Human Papillomavirus Genotypes, According to the Human Immunodeficiency Virus Status in a Cohort of Women from Maputo, Mozambique
por: Maueia, Cremildo, et al.
Publicado: (2021)

HPV vaccination and HIV preexposure prophylaxis (PrEP): Missed opportunities for anal cancer prevention among at risk populations
por: Wheldon, Christopher W.
Publicado: (2022)

Perioperative concerns in neurosurgical patients with human immunodeficiency virus infection
por: Agarwal, Jyotsna, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_54aafms3de2l3t25kk1s2hm3in